TECH vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

TECH

51.1
AI Score
VS
TECH Wins

MRNA

42.9
AI Score

Investment Advisor Scores

TECH

51score
Recommendation
HOLD

MRNA

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric TECH MRNA Winner
Revenue 893.85M 534.00M TECH
Net Income 127.24M -2.13B TECH
Net Margin 14.2% -397.9% TECH
Operating Income 177.61M -2.20B TECH
ROE 6.1% -31.4% TECH
ROA 5.0% -19.4% TECH
Total Assets 2.55B 10.96B MRNA
Cash 209.82M 1.72B MRNA
Current Ratio 4.49 2.29 TECH
Free Cash Flow 176.29M -1.25B TECH

Relative Price Performance (Last 90 Days)

TECH 1M: +0.8% · 3M: +52.7% MRNA 1M: +154.5% · 3M: +207.1%

Current Technical Phase

TECH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.5% over 20 days), RSI 70

RSI (14): 69.5 · Price: $72.32

MRNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (17.2% over 20 days), RSI 72

RSI (14): 71.6 · Price: $145.13

Fundamentals Snapshot

Metric TECH MRNA
Market Cap
Forward P/E 43.3 -29.8
Trailing P/E 61.9
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.7% -0.7%
Operating Margin 0.2% -5.6%
EPS 1.17 -6.11
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, TECH is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.